Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Heiman

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
ACS Applied Nano Materials|June 25, 2024
Exchange Bias in Bulk <math><mrow><mi>α</mi> <mo>-</mo> <mtext>Fe</mtext> <mo>/</mo> <mi>γ</mi> <mo>-</mo> <msub><mrow><mtext>Fe</mtext></mrow> <mrow><mn>70</mn></mrow></msub> <msub><mrow><mtext>Mn</mtext></mrow> <mrow><mn>30</mn></mrow></msub></mrow></math> Nanocomposites for Permanent Magnet ApplicationsI J McDonald, M E Jamer, K L Krycka, et al.
Neurology|November 15, 2006
The ALSSQOL: balancing physical and nonphysical factors in assessing quality of life in ALSZ Simmons, S H Felgoise, B A Bremer, et al.
Journal of Clinical Neuromuscular Disease|February 25, 2016
Primary Lateral Sclerosis and Early Upper Motor Neuron Disease: Characteristics of a Cross-Sectional PopulationChristina N Fournier, Alyssa Murphy, Lorena Loci, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 18, 2018
Understanding the use of NIV in ALS: results of an international ALS specialist surveyTerry D Heiman-Patterson, Merit E Cudkowicz, Mamede De Carvalho, et al.
Human Molecular Genetics|December 7, 2018
Hereditary spastic paraplegia: gain-of-function mechanisms revealed by new transgenic mouseLiang Qiang, Emanuela Piermarini, Hemalatha Muralidharan, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 21, 2024
Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTDMichael Benatar, Terry D Heiman-Patterson, Johnathan Cooper-Knock, et al.
Neurology|August 27, 2003
A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosisM E Cudkowicz, J M Shefner, D A Schoenfeld, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2022
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trialSabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
Muscle & Nerve|October 16, 2020
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosisSabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
Neuron|March 24, 2018
Genome-wide Analyses Identify KIF5A as a Novel ALS GeneAude Nicolas, Kevin P Kenna, Alan E Renton, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
ACS Applied Nano Materials|June 25, 2024
Exchange Bias in Bulk <math><mrow><mi>α</mi> <mo>-</mo> <mtext>Fe</mtext> <mo>/</mo> <mi>γ</mi> <mo>-</mo> <msub><mrow><mtext>Fe</mtext></mrow> <mrow><mn>70</mn></mrow></msub> <msub><mrow><mtext>Mn</mtext></mrow> <mrow><mn>30</mn></mrow></msub></mrow></math> Nanocomposites for Permanent Magnet ApplicationsI J McDonald, M E Jamer, K L Krycka, et al.
Neurology|November 15, 2006
The ALSSQOL: balancing physical and nonphysical factors in assessing quality of life in ALSZ Simmons, S H Felgoise, B A Bremer, et al.
Journal of Clinical Neuromuscular Disease|February 25, 2016
Primary Lateral Sclerosis and Early Upper Motor Neuron Disease: Characteristics of a Cross-Sectional PopulationChristina N Fournier, Alyssa Murphy, Lorena Loci, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 18, 2018
Understanding the use of NIV in ALS: results of an international ALS specialist surveyTerry D Heiman-Patterson, Merit E Cudkowicz, Mamede De Carvalho, et al.
Human Molecular Genetics|December 7, 2018
Hereditary spastic paraplegia: gain-of-function mechanisms revealed by new transgenic mouseLiang Qiang, Emanuela Piermarini, Hemalatha Muralidharan, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 21, 2024
Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTDMichael Benatar, Terry D Heiman-Patterson, Johnathan Cooper-Knock, et al.
Neurology|August 27, 2003
A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosisM E Cudkowicz, J M Shefner, D A Schoenfeld, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2022
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trialSabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
Muscle & Nerve|October 16, 2020
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosisSabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
Neuron|March 24, 2018
Genome-wide Analyses Identify KIF5A as a Novel ALS GeneAude Nicolas, Kevin P Kenna, Alan E Renton, et al.
Pageof 7